Boltansky Howard MD Washington, DC - 20016

Boltansky Howard MD is categorized under Allergists in Washington, DC and active since 1992.

Boltansky Howard MD was established in 1992, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Allergists business, which does work in the B2C market, and is classified as a Allergists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Howard Boltansky at the company’s single location by writing to 3301 New Mexico Avenue Nw # 223, Washington, District of Columbia DC 20016 or by phoning (202) 966-7100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Boltansky Howard MD
Contact Person: Howard Boltansky
Address: 3301 New Mexico Avenue Nw # 223, Washington, District of Columbia 20016
Phone Number: (202) 966-7100
Website Address: boltansky-brody.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1992
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Allergists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Boltansky Howard MD was started in 1992 to provide professional Allergists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Howard Boltansky for inquiries that concern Boltansky Howard MD by calling the company number (202) 966-7100, as your correspondence is most welcome. Additionally, the physical location of the single location of Boltansky Howard MD can be found at the coordinates 38.935337,-77.086936 as well as the street address 3301 New Mexico Avenue Nw # 223 in Washington, District of Columbia 20016.

For its online presence, you may visit Boltansky Howard MD’s website at boltansky-brody.com and engage with its social media outlets through on Twitter and on Facebook.